---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-040903"
form_type: "8-K"
ticker: "TNON"
cik: "0001560293"
company_name: "Tenon Medical, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T09:55:32.724365+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tenon Medical receives Nasdaq bid price deficiency notice; stock below $1.00 for 30 days

## Summary
- Nasdaq letter dated May 7, 2024, citing 30 consecutive business days below $1.00 minimum bid price from Mar 25 to May 6.
- Initial 180-day compliance period runs until November 4, 2024, to regain compliance with Bid Price Rule.
- If not cured, company may qualify for a second 180-day period if it meets other listing standards and notifies intent to cure.
- Company is evaluating options; no immediate impact on listing, but no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001213900-24-040903
- form_type: 8-K
- ticker: TNON
- cik: 0001560293
- company_name: Tenon Medical, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560293/000121390024040903/0001213900-24-040903-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560293/000121390024040903/ea0205567-8k_tenon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-040903
- JSON: https://secwatch.observer/filing/0001213900-24-040903.json
- Plain text: https://secwatch.observer/filing/0001213900-24-040903.txt

## Key facts
- Listing & Compliance Notices
  Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: ule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial
  evidence_url: https://www.sec.gov/Archives/edgar/data/1560293/000121390024040903/0001213900-24-040903-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.